American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

CytoMed Therapeutics Ltd (GDTC)

$0.99 +12.50% NASDAQ: GDTC · 15-min delayed

Public · NASDAQ: GDTC
42 employees

Visit website Follow

$15.3MMarket cap

42Employees

GDTCNASDAQ

2023IPO

About CytoMed Therapeutics Ltd

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · NASDAQ: GDTC
Employees: 42
IPO date: Apr 14, 2023
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: GDTC Nasdaq
SEC CIK: 1873093
SIC: 2834 Pharmaceutical Preparations

Embed this company’s badge

Show CytoMed Therapeutics Ltd’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/cytomed-therapeutics-ltd/"><img src="https://americancompanies.com/badge/cytomed-therapeutics-ltd.svg" alt="CytoMed Therapeutics Ltd — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow CytoMed Therapeutics Ltd and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Market cap: $15.3M

NASDAQ: GDTC

$0.99 +12.50%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.72 $2.69

52-week range

Market cap: $15.3M
Shares outstanding: 15.4M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Apr 14, 2023

CytoMed Therapeutics Ltd (GDTC) Stock Price

Trading 63% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review CytoMed Therapeutics Ltd.

Write a review

Newsroom

News about CytoMed Therapeutics Ltd

CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India Benzinga · 2025-11-18 · positive Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now - GlobeNewswire GlobeNewswire Inc. · 2024-07-17 · positive Wall Street Breakfast: The Week Ahead Seeking Alpha · 2024-04-14 CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies GlobeNewswire Inc. · 2024-03-18 CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair GlobeNewswire Inc. · 2024-03-04 Why Container Store Group Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Benzinga · 2024-02-07

News & sentiment via Polygon.io

FAQ

CytoMed Therapeutics Ltd: frequently asked questions

Is CytoMed Therapeutics Ltd an American company?

CytoMed Therapeutics Ltd is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is CytoMed Therapeutics Ltd publicly traded?

Yes — CytoMed Therapeutics Ltd is a publicly traded company. Its stock trades under the ticker symbol GDTC on the NASDAQ.

What does CytoMed Therapeutics Ltd do?

CytoMed Therapeutics Ltd is an American Pharmaceuticals company in the Health & Beauty sector.

Explore